Back to Search
SILVIU ITESCU, MD
MD
Clinical & Laboratory Immunology (Allergy & Immunology) Physician
NPI: 1710065925Individual
Specialties, Licenses & Credentials
Clinical & Laboratory Immunology (Allergy & Immunology) PhysicianPrimary
Allergy & Immunology — Clinical & Laboratory Immunology
Code: 207KI0005X
200495-1(NY)
Research & Publications (20)
New directions in strategies using cell therapy for heart disease.
PMID 12698252·J Mol Med (Berl)·2003
6-review
Interactions between the recipient immune system and the left ventricular assist device surface: immunological and clinical implications.
PMID 12820736·Ann Thorac Surg·2003
6-review
Myocardial neovascularization by adult bone marrow-derived angioblasts: strategies for improvement of cardiomyocyte function.
PMID 12878834·Heart Fail Rev·2003
6-review
Myocardial neovascularization by adult bone marrow-derived angioblasts: strategies for improvement of cardiomyocyte function.
PMID 12611063·Ann Hematol·2002
6-review
Intravenous pulse administration of cyclophosphamide is an effective and safe treatment for sensitized cardiac allograft recipients.
PMID 11889016·Circulation·2002
3-trial
Transendothelial migration and infiltration of porcine xenografts by primate monocytes requires natural killer cell-dependent activation.
PMID 10936367·Transplant Proc·2000
7-preclinical
Heat shock protein-90 beta is expressed at the surface of multipotential mesenchymal precursor cells: generation of a novel monoclonal antibody, STRO-4, with specificity for mesenchymal precursor cells from human and ovine tissues.
PMID 19327008·Stem Cells Dev·2009
7-preclinical
Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage.
PMID 19231391·Ann Thorac Surg·2009
7-preclinical
Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor, and an intracoronary CD133+ cell infusion in patients with chronic refractory ischemic heart disease: the G-CSF in angina patients with IHD to stimulate neovascularization (GAIN I) trial.
PMID 19061712·Am Heart J·2008
2-rct
CCR3- and CXCR4-mediated interactions regulate migration of CD34+ human bone marrow progenitors to ischemic myocardium and subsequent tissue repair.
PMID 18954648·J Thorac Cardiovasc Surg·2008
7-preclinical
Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo.
PMID 17654479·J Cell Physiol·2008
7-preclinical
Human mulipotential mesenchymal/stromal stem cells are derived from a discrete subpopulation of STRO-1bright/CD34 /CD45(-)/glycophorin-A-bone marrow cells.
PMID 18055998·Haematologica·2007
8-other
A DNA enzyme against plasminogen activator inhibitor- type 1 (PAI-1) limits neointima formation after angioplasty in an obese diabetic rodent model.
PMID 18091579·J Cardiovasc Pharmacol·2007
7-preclinical
The changing pattern of humoral rejection in cardiac transplant recipients.
PMID 17713434·Transplantation·2007
8-other
Cardiac tissue engineering in an in vivo vascularized chamber.
PMID 17200440·Circulation·2007
7-preclinical
Anti-CD25 treatment and FOXP3-positive regulatory T cells in heart transplantation.
PMID 17584597·Transpl Immunol·2007
8-other
A novel monoclonal antibody (STRO-3) identifies an isoform of tissue nonspecific alkaline phosphatase expressed by multipotent bone marrow stromal stem cells.
PMID 18158854·Stem Cells Dev·2007
8-other
Mesenchymal lineage precursor cells induce vascular network formation in ischemic myocardium.
PMID 16501624·Nat Clin Pract Cardiovasc Med·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 177 FORT WASHINGTON AVE, 7-453GN
NEW YORK, NY 10032 - Phone
- (201) 447-8717
Quick Facts
- NPI
- 1710065925
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile